31 results
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
16 Apr 24
InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration
2:39pm
, accounting for 85-90% of all AMD cases and is a leading cause of blindness in the developed world. Dry AMD is caused by waste proteins and lipids (oily … material) that begin to accumulate due to poor circulation and poor waste-flushing in the eye. The advanced stage of dry AMD is referred
424B5
INM
InMed Pharmaceuticals Inc
3 Jun 22
Prospectus supplement for primary offering
9:45pm
hazardous materials and chemicals. Our operations may produce hazardous waste products. Although we believe that our safety procedures for handling
424B3
INM
InMed Pharmaceuticals Inc
25 Apr 22
Prospectus supplement
5:02pm
, and may in the future involve, the use of potentially hazardous materials and chemicals. Our operations may produce hazardous waste products. Although
424B3
3kevtaqdhky s9
7 Apr 22
Prospectus supplement
4:46pm
S-3
7s1lie9jvld7
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
cspjv00g
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
e7yj vh6hl2r
24 Sep 21
Annual report
7:31am
10-K
xhjrdhk
24 Sep 21
Annual report
7:31am
424B3
m9afw2rh dsfbrtv
22 Jul 21
Prospectus supplement
10:27am
424B3
pwl6 pirwf
16 Mar 21
Prospectus supplement
12:00am
10-Q
4r2s5jwv0wev2g4isqn
17 Dec 20
Quarterly report
12:00am
424B4
bs8dn
13 Nov 20
Prospectus supplement with pricing info
8:52pm